411 related articles for article (PubMed ID: 16624621)
61. Gene therapy. What to do when clear success comes with an unclear risk?
Marshall E
Science; 2002 Oct; 298(5593):510-1. PubMed ID: 12386304
[No Abstract] [Full Text] [Related]
62. Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice.
Westwood JA; Murray WK; Trivett M; Shin A; Neeson P; MacGregor DP; Haynes NM; Trapani JA; Mayura-Guru P; Fox S; Peinert S; Honemann D; Prince HM; Ritchie D; Scott AM; Smyth FE; Smyth MJ; Darcy PK; Kershaw MH
Gene Ther; 2008 Jul; 15(14):1056-66. PubMed ID: 18369322
[TBL] [Abstract][Full Text] [Related]
63. Cellular gene therapy.
Lee JH; Klein HG
Hematol Oncol Clin North Am; 1995 Feb; 9(1):91-113. PubMed ID: 7737946
[TBL] [Abstract][Full Text] [Related]
64. Transcription start regions in the human genome are favored targets for MLV integration.
Wu X; Li Y; Crise B; Burgess SM
Science; 2003 Jun; 300(5626):1749-51. PubMed ID: 12805549
[TBL] [Abstract][Full Text] [Related]
65. Gene therapy. Panel urges limits on X-SCID trials.
Kaiser J
Science; 2005 Mar; 307(5715):1544-5. PubMed ID: 15761128
[No Abstract] [Full Text] [Related]
66. Physiological promoters reduce the genotoxic risk of integrating gene vectors.
Zychlinski D; Schambach A; Modlich U; Maetzig T; Meyer J; Grassman E; Mishra A; Baum C
Mol Ther; 2008 Apr; 16(4):718-25. PubMed ID: 18334985
[TBL] [Abstract][Full Text] [Related]
67. A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors.
Schucht R; Coroadinha AS; Zanta-Boussif MA; Verhoeyen E; Carrondo MJ; Hauser H; Wirth D
Mol Ther; 2006 Aug; 14(2):285-92. PubMed ID: 16697259
[TBL] [Abstract][Full Text] [Related]
68. Bubble babies and bathwater.
Nat Biotechnol; 2002 Nov; 20(11):1063. PubMed ID: 12410236
[No Abstract] [Full Text] [Related]
69. Genome-wide analysis of retroviral DNA integration.
Bushman F; Lewinski M; Ciuffi A; Barr S; Leipzig J; Hannenhalli S; Hoffmann C
Nat Rev Microbiol; 2005 Nov; 3(11):848-58. PubMed ID: 16175173
[TBL] [Abstract][Full Text] [Related]
70. Clinical research. Gene therapy a suspect in leukemia-like disease.
Marshall E
Science; 2002 Oct; 298(5591):34-5. PubMed ID: 12364755
[No Abstract] [Full Text] [Related]
71. The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors.
Wilson CA; Cichutek K
Methods Mol Biol; 2009; 506():477-88. PubMed ID: 19110646
[TBL] [Abstract][Full Text] [Related]
72. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
[TBL] [Abstract][Full Text] [Related]
73. Gene therapy: therapeutic gene causing lymphoma.
Woods NB; Bottero V; Schmidt M; von Kalle C; Verma IM
Nature; 2006 Apr; 440(7088):1123. PubMed ID: 16641981
[TBL] [Abstract][Full Text] [Related]
74. Retroviral DNA integration.
Coffin JM
Dev Biol Stand; 1992; 76():141-51. PubMed ID: 1478335
[TBL] [Abstract][Full Text] [Related]
75. Murine leukemia induced by retroviral gene marking.
Li Z; Düllmann J; Schiedlmeier B; Schmidt M; von Kalle C; Meyer J; Forster M; Stocking C; Wahlers A; Frank O; Ostertag W; Kühlcke K; Eckert HG; Fehse B; Baum C
Science; 2002 Apr; 296(5567):497. PubMed ID: 11964471
[No Abstract] [Full Text] [Related]
76. Gene transfer to somatic tissues using retroviral vectors.
Moullier P; Marechal V; Ferry N; Naffakh N; Heard JM; Danos O
Nouv Rev Fr Hematol (1978); 1991; 33(6):493-5. PubMed ID: 1818305
[TBL] [Abstract][Full Text] [Related]
77. Harmful potential of viral vectors fuels doubts over gene therapy.
Check E
Nature; 2003 Jun; 423(6940):573-4. PubMed ID: 12789298
[No Abstract] [Full Text] [Related]
78. Integration site selection by retroviruses.
Cereseto A; Giacca M
AIDS Rev; 2004; 6(1):13-21. PubMed ID: 15168737
[TBL] [Abstract][Full Text] [Related]
79. Concise review: managing genotoxicity in the therapeutic modification of stem cells.
Baum C; Modlich U; Göhring G; Schlegelberger B
Stem Cells; 2011 Oct; 29(10):1479-84. PubMed ID: 21898683
[TBL] [Abstract][Full Text] [Related]
80. Gene therapy bio-safety: scientific and regulatory issues.
Gonin P; Buchholz CJ; Pallardy M; Mezzina M
Gene Ther; 2005 Oct; 12 Suppl 1():S146-52. PubMed ID: 16231047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]